drugs

Another reason to be glad HUSKY fired managed care

New favorite quote – “If you have a dumb incentive system, you get dumb outcomes.” Charlie Munger, quoted by 46brooklyn A new analysis by 46brooklyn highlights the extra costs to Medicaid managed care programs of drug industry middlemen. Ohio’s Medicaid program pays $224 extra in markups to Pharmacy Benefit Managers (PBMs) hired by managed care…

Read More

Lidocaine patch leads CT Medicaid drug spending

According to the latest data visualization from 46brooklyn, CT’s Medicaid program is spending a lot on lidocaine patches. Lidocaine is a local anesthetic that relieves nerve pain. Over the last three available quarters (Q3,4 2017 and Q1 2018), Lidocaine patches have topped CT Medicaid’s list of 25 most costly medications. This medication isn’t on the…

Read More

Rash of New Haven overdoses the latest in a growing CT problem

The New Haven Register is reporting that there’ve been 80 overdoses on the Green in the last two days.  Two patients overdosed three times each Wednesday. It was ongoing earlier this afternoon.  DPH delivered 50 more doses of naloxone to city first responders and is facilitating communications between city agencies. DMHAS has engaged mental health…

Read More

Good news – FDA committee reviewing lots more antibiotics

The best news from this week’s FDA Anti-Microbial Advisory Committee meeting was that there are a lot of meetings. A busy committee means that they have more antibiotics to review. The race against drug-resistant superbugs has reduced incentives for drug companies to develop antibiotics. These drugs cost as much to develop as others but are…

Read More

Last year CT physicians and teaching hospitals received $34 million from manufacturers and GPOs

New data shows that 21 teaching hospitals and 13,310 physicians in CT received $34 million in payments and gifts from drug and device manufacturers and Group Purchasing Organizations (GPOs) last year. Open Payments, the searchable federal data source, was created by the Affordable Care Act which requires that manufacturers disclose payments to physicians and teaching…

Read More

ICER to report on unjustified drug price increases

Early next year, the nonprofit Institute for Clinical and Economic Review (ICER) will issue its first report on US drug price increases that are not supported by clinical evidence. ICER is a leader in assessing the value of medical treatments, including medications. ICER’s benchmark price ranges for new drugs have been used by Medicaid programs,…

Read More

31 ways to save on healthcare in Connecticut’s budget

Connecticut’s state budget is facing future deficits and health spending is a large share of the budget. The state now spends $3.8 billion between Medicaid and the state employee health plan to cover about a million state residents. Health care spending outside the state budget is also growing. Connecticut has the sixth highest per capita…

Read More

WNPR’s Where We Live focuses on skyrocketing prescription costs, ACA protections at risk

Yesterday, WNPR’s Where We Live, “Sick of the Cost of Prescription Drugs?”, drilled down into the rising costs of prescription drugs that are squeezing out other priorities and on Trump administration ACA policies that jeopardize coverage for people with preexisiting conditions and raise premiums for everyone. Guests included US Senator Chris Murphy, State Rep. Sean…

Read More
Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
ErrorHere